CIK 0001781983
- Non-accelerated filer
- Smaller reporting company
Aprea Therapeutics, Inc.
Sign in to watch- Ticker
- APRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 215-948-4119
- Business address
- 3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-10-07 | Redmile Group, LLC 10% owner | Conversion · Series C Preferred Stock | −1,164,674 | 0 | ||
| 2019-10-07 | Versant Vantage I, L.P. 10% owner | Conversion | +1,993,658 | 2,006,328 | ||
| 2019-10-07 | Versant Vantage I, L.P. 10% owner | Conversion | +512,995 | 2,519,323 | ||
| 2019-10-07 | Versant Vantage I, L.P. 10% owner | Purchase | +333,333 | $15.00 | $5.0M | 333,333 |
| 2019-10-07 | Versant Vantage I, L.P. 10% owner | Conversion · Series B Convertible Preferred Stock | −1,993,658 | 0 | ||
| 2019-10-07 | Versant Vantage I, L.P. 10% owner | Conversion · Series C Convertible Preferred Stock | −512,995 | 0 | ||
| 2019-10-07 | Versant V Luxco S.a r.l. 10% owner | Conversion | +1,993,658 | 2,006,328 | ||
| 2019-10-07 | Versant V Luxco S.a r.l. 10% owner | Conversion | +512,995 | 2,519,323 | ||
| 2019-10-07 | Versant V Luxco S.a r.l. 10% owner | Purchase | +333,333 | $15.00 | $5.0M | 333,333 |
| 2019-10-07 | Versant V Luxco S.a r.l. 10% owner | Conversion · Series B Convertible Preferred Stock | −1,993,658 | 0 | ||
| 2019-10-07 | Versant V Luxco S.a r.l. 10% owner | Conversion · Series C Convertible Preferred Stock | −512,995 | 0 | ||
| 2019-10-07 | Christenson Johan Director | Conversion | +1,661,382 | 1,671,941 | ||
| 2019-10-07 | Christenson Johan Director | Conversion | +427,496 | 2,099,437 | ||
| 2019-10-07 | Christenson Johan Director | Purchase | +266,667 | $15.00 | $4.0M | 2,366,104 |
| 2019-10-07 | Christenson Johan Director | Conversion · Series B Convertible Preferred Stock | −1,661,382 | 0 | ||
| 2019-10-07 | Christenson Johan Director | Conversion · Series C Convertible Preferred Stock | −427,496 | 0 | ||
| 2019-10-07 | Seizinger Bernd R. Director | Option exercise | +263,970 | $0.07 | $18K | 263,970 |
| 2019-10-07 | Seizinger Bernd R. Director | Option exercise · Stock Option (right to buy) | −263,970 | 0 | ||
| 2019-10-07 | ROCKLAGE SCOTT M Director | Conversion | +1,913,910 | 1,926,073 | ||
| 2019-10-07 | ROCKLAGE SCOTT M Director | Conversion | +79,746 | 80,253 |
Page 15 of 17 · 334 trades